A targeted disruption of the murine complement factor B gene resulting in loss of expression of three genes in close proximity, factor B, C2, and D17H6S45

被引:48
作者
Taylor, PR [1 ]
Nash, JT [1 ]
Theodoridis, E [1 ]
Bygrave, AE [1 ]
Walport, MJ [1 ]
Botto, M [1 ]
机构
[1] Hammersmith Hosp, Imperial Coll, Sch Med, Div Med,Rheumatol Sect, London W12 0NN, England
关键词
D O I
10.1074/jbc.273.3.1699
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Factor B is a serine protease, essential for the function of the alternative pathway of complement activation, To study further the importance of the alternative pathway of complement activation in vivo and to help elucidate any additional functions of factor B or its activation fragments we developed, by homologous recombination in embryonic stem cells, mice with a disrupted factor B gene. Factor B-deficient mice produced no detectable factor B mRNA or protein and had no detectable factor B enzymatic activity or alternative pathway function in their serum, Further studies revealed that the two adjacent genes, complement component C2 and D17H6S45, had been down regulated as a result of the disruption, The down-regulation of C2 gene expression was sufficient to cause a complete loss of classical pathway function as determined by the failure of sera from the deficient mice to opsonize antibody-sensitized sheep erythrocytes and by impairment of immune complex processing in vivo, The resulting mouse is deficient in both factor B and C2, and hence the alternative and classical pathways of complement activation, and adds to the repertoire of models for studying the in vivo role of complement in the immune system.
引用
收藏
页码:1699 / 1704
页数:6
相关论文
共 49 条
[1]   STUDIES OF HEPATIC SYNTHESIS INVIVO OF PLASMA-PROTEINS, INCLUDING OROSOMUCOID, TRANSFERRIN, ALPHA-1-ANTITRYPSIN, C8, AND FACTOR-B [J].
ALPER, CA ;
RAUM, D ;
AWDEH, ZL ;
PETERSEN, BH ;
TAYLOR, PD ;
STARZL, TE .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1980, 16 (01) :84-89
[2]  
Altman PL, 1961, BLOOD OTHER BODY FLU, P9
[3]  
AMBRUS JL, 1990, J IMMUNOL, V144, P1549
[4]   MICROASSAY FOR DETERMINATION OF HEMOLYTIC COMPLEMENT ACTIVITY IN MOUSE SERUM [J].
ANDREWS, BS ;
THEOFILOPOULOS, AN .
JOURNAL OF IMMUNOLOGICAL METHODS, 1978, 22 (3-4) :273-281
[5]   MAZ-DEPENDENT TERMINATION BETWEEN CLOSELY SPACED HUMAN-COMPLEMENT GENES [J].
ASHFIELD, R ;
PATEL, AJ ;
BOSSONE, SA ;
BROWN, H ;
CAMPBELL, RD ;
MARCU, KB ;
PROUDFOOT, NJ .
EMBO JOURNAL, 1994, 13 (23) :5656-5667
[6]   TRANSCRIPTIONAL TERMINATION BETWEEN THE CLOSELY LINKED HUMAN-COMPLEMENT GENES C2 AND FACTOR-B - COMMON TERMINATION FACTOR FOR C2 AND C-MYC [J].
ASHFIELD, R ;
ENRIQUEZHARRIS, P ;
PROUDFOOT, NJ .
EMBO JOURNAL, 1991, 10 (13) :4197-4207
[7]  
BOTTO M, 1996, MOL IMMUNOL S1, V33, P71
[8]  
BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P886
[9]   RECOMBINATION WITHIN THE YEAST PLASMID 2-MU CIRCLE IS SITE-SPECIFIC [J].
BROACH, JR ;
GUARASCIO, VR ;
JAYARAM, M .
CELL, 1982, 29 (01) :227-234
[10]   MOLECULAR MAP OF THE MURINE S-REGION [J].
CHAPLIN, DD ;
WOODS, DE ;
WHITEHEAD, AS ;
GOLDBERGER, G ;
COLTEN, HR ;
SEIDMAN, JG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (22) :6947-6951